
Fadi Antaki MD
Professor of Medicine, Wayne State University School of Medicine, GI Section chief, John D. Dingell VA Medical Center
Join to View Full Profile
4646 John R streetDetroit, MI 48201
Phone+1 313-576-1000
Fax+1 313-576-1237
Dr. Antaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Fadi Antaki is a gastroenterologist based in Detroit, MI, with a background that includes a fellowship and residency at Henry Ford Hospital. He graduated from the University of Aleppo Faculty of Medicine in 1998. Dr. Antaki is currently a professor at Wayne State University School of Medicine, having previously served as an associate and assistant professor there. His expertise encompasses areas such as general gastroenterology, hepatitis B, hepatitis C, hepatic cirrhosis, and endoscopy. He has contributed to research, as evidenced by his publications in reputable journals, with topics covering colorectal neoplasia prediction and endoscopic techniques. Additionally, Dr. Antaki is involved in clinical trials focusing on colorectal cancer and Clostridium difficile treatment.
Education & Training
- Henry Ford Health/Henry Ford HospitalFellowship, Gastroenterology, 2003 - 2006
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2000 - 2003
- University of Aleppo Faculty of MedicineClass of 1998
Certifications & Licensure
- MI State Medical License 2008 - 2028
- MA State Medical License 2006 - 2017
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Start of enrollment: 2012 Apr 30
- Non-Invasive Prediction of Colorectal Neoplasia Start of enrollment: 2006 Aug 01
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- Historic p87 Is Diagnostic for Lung Cancer Preceding Clinical Presentation by at Least 4 Years.Martin Tobi, Daniel Ezekwudo, Yosef Y Tobi, Xiaoqing Zhao, Fadi Antaki
Cancers. 2025-03-12 - Inflammatory Bowel Disease from the Perspective of Newer Innate Immune System Biomarkers.Martin Tobi, Fadi Antaki, MaryAnn Rambus, Jason Hellman, James Hatfield
Gastrointestinal Disorders. 2025-03-06 - 3 citationsThe Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody,...Martin Tobi, Fadi Antaki, Mary Ann Rambus, Yu-Xiao Yang, David Kaplan
International Journal of Molecular Sciences. 2023-12-08
Authored Content
- Tu1109 COMPLIANCE AND TOLERABILITY OF SPLIT DOSE BOWEL PREPARATION IN VETERANS WITH PRIOR USE OF PM-ONLY BOWEL PREPARATIONMay 2018
- Tu1109 COMPLIANCE AND TOLERABILITY OF SPLIT DOSE BOWEL PREPARATION IN VETERANS WITH PRIOR USE OF PM-ONLY BOWEL PREPARATIONMay 2018
Press Mentions
- School Celebrates Faculty Promotions, Tenure and Awards Sept. 29September 8th, 2022
Professional Memberships
- Member
- Fellow
- Fellow
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: